1Buchanan TA,Xiang AH,Peters PK,et al.Preservation of pancreatic (beta)-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin res:stanle in high-risk hispanic women.Diabetes,20 02,51:2796-2803.
2UK prospective diabetes study (UKPDS) Group.Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes.Lancet,1998,352:837 -853.
3Lefebvre PJ,Sscheen AJ.The postprandial state and risk of cardiovascular disease.Diabetes Medicine,1998,15:S63-68.
4Ceriello A.Postprandial hyperglycemia and diabetes complications:is it time to treat? Diabetes,2005,54:1-7.
5Sheetz MJ,King GL.Molecular understanding of hyperglycemia's adverse effects for diabetic complications.JAMA,2002,288:2579-2588.
6Ceriello A.Impaired glucose tolerance and cardiovascular disease:the possible role of post-prandial hyperglycemia.Am Heart J,2004,147:803-807.
7Moreno PR,Fuster V.New aspects in the pathogenesis of diabetic ather othrombosis.J Am Coll Cardiol,2004,44:2293-2300.
8Woodman RJ,Chew GT,Watts GF.Mechanisms,significance and treatment of vascular dysfunction in type 2 diabetes mellitus:focus on lipid-regulating therapy.Drugs,2005,65:31-74.
9Kowalska IR,Straczkowski M.Circulating E-selectin,vascular cell adhesion molecule-1,and intercellular adhesion molecule-1 in men with coronary artery disease assessed by angiography and disturbances of carbohydrate metabolism.Metabolism,2002,51:733-736.
10Bluher M,Unger R.Relation between glcaemic control hyperinsulinaem ia and plasma concentrations of soluble adhesion molecules in patients with impaired glucose toleranceor type 2 diabetes.Diabetologia,2002,45:210-216.
